APPI Bulletin - 06/30/2008

If this page doesn't display properly in your email, click here.

June 30, 2008


APPI Home Career Center Code of Ethics Regional Chapters Events Calendar Readings, Resources, & Events of Interest According to a June 24 New York Times editorial about electronic health records, "It is time to drag private physicians out of the paper age." The Academy and APPI have launched a campaign to support a federal effort to honor patient participants in clinical trials. The effort is embodied in House Resolution 248, which encourages public recognition of clinical trial participants, and we need your help. For more information, click here. The April 2008 issue of IFAPP World, a publication of the International Federation of Associations of Pharmaceutical Physicians, is available for download here. The 15th International Conference on Pharmaceutical Medicine (ICPM 2008), organized by the International Federation of Associations of Pharmaceutical Physicians, will be held in Amsterdam, The Netherlands, September 7–10. The Call for Proposals for the ACRP 2009 Global Conference & Exhibition with the APPI Physicians Program in Denver has a deadline of June 30, 2008. Details are available at www.acrp2009.org. The deadline for nominations for the APPI Board of Trustees is August 29, 2008. For more information and a link to the nomination form, click here.

Print-Friendly Version RSS Search Back Issues Forward this Issue Subscribe Manage Your Subscription

First Gene Therapy for Heart Failure Offered at Medical Center

Could injecting a gene into patients with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure....Read More

Perspective: Policies Must Keep Pace with Genetic Progress

Enactment of the Genetic Information Nondiscrimination Act (GINA) is a boon to individual patients and for genetic research, according the the authors of a perspective article in the New England Journal of Medicine, but they note that employers, health insurers, patients, and doctors now must be educated about its provisions, that gaps remain in genetic testing oversight, and that there still may be opportunities to misuse genetic information....Read More

Same Drug, Different Results: Researcher on the Path to Personalized Medicine

Medicine has moved a little bit closer to the era of tailor-made treatments, based on the unique genetic profiles of individual patients, according to recent research conducted at the Montreal Children's Hospital and McGill University and published in the journal Pharmacogenetics and Genomics. The study shows how minor genetic differences between individuals alter the way a common drug affects the body....Read More

Effective Treatment for Sickle Cell Underused by Doctors

Uncertainties about proper use and possible long-term effects of hydroxyurea in the treatment of sickle cell anemia may be wrongly influencing doctors to avoid prescribing it to those in serious need, according to results of a literature review by specialists at Johns Hopkins....Read More

© 2007-2008 Academy of Pharmaceutical Physicians and Investigators. All Rights Reserved.

APPI is the voice of pharmaceutical physicians and physician investigators

Please send comments/questions about the Bulletin to gary@acrpnet.org

500 Montgomery Street, Suite 800 | Alexandria, VA 22314

To ensure delivery of the APPI Bulletin please add acrpnews@acrpnet.org to your e-mail address book or Safe Sender List. If you are still having problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Click Here to unsubscribe